SABBY Management, LLC, 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 194,421 shares at $0.26 ($47K) on 2019-01-16, disclosed to the SEC on 2019-01-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.24 | 167,760 | $40K | 84.9% |
| 2 | $0.26 | 4,700 | $1K | 2.6% |
| 3 | $0.27 | 21,961 | $6K | 12.5% |
| Total | $0.24 avg | 194,421 | $47K | 100% |
| Filing → |
| VLCN | BUY | 2024-08-28 | $5K | — | Filing → |
| VLCN | BUY | 2024-08-26 | $11K | — | Filing → |
| VLCN | SELL | 2024-08-26 | $134K | — | Filing → |